Dexlansoprazole
Brand names: Dexilant, Dexlansoprazole Dr
At a glance
- Medicare prescriptions, 2024
- 564,346
- Medicare drug cost
- $143.5M
- Average cost per prescription
- $254
- Clinicians who prescribed it
- 19,402
Where it is prescribed
List the prescribers in any state, county, city or ZIP code →
What it is used for
Dexlansoprazole delayed-release capsules are proton pump inhibitor (PPI) indicated in patients 12 years of age and older for: Healing of all grades of erosive esophagitis (EE). Maintenance of healed EE and relief of heartburn. Treatment of symptomatic non-erosive gastroesophageal reflux disease (GERD). 1.1 Healing of Erosive Esophagitis Dexlansoprazole delayed-release capsules
From the FDA-approved prescribing information (label dated May 2026). Full labels on DailyMed (opens in a new tab)
Who prescribes it
- Internal Medicine 25.8%
- Family Medicine 21.2%
- Gastroenterology 20.3%
- Nurse Practitioners 16.2%
- Physician Assistants 7.4%
- General Practice 1.7%
- Cardiology 1.3%
- Geriatric Medicine 1.0%
- Nephrology (Kidney) 0.9%
- General Surgery 0.4%
- ENT (Otolaryngology) 0.4%
- Pulmonology 0.4%
All prescribers, by place, name or specialty →
Share of Medicare prescriptions written by each specialty. Select one to list its prescribers.
Trend, 2019–2024
Medicare prescriptions fell 38% from 2019 to 2024.
Biggest change by state since 2019
- Puerto Rico −9%
- Alabama −21%
- Kentucky −26%
- Maryland −29%
- Virginia −30%
- West Virginia (smallest change) −62%
- Louisiana (smallest change) −54%
From CMS’s yearly state and national Part D summaries, which count every prescriber, including those CMS leaves out of its per-clinician data (fewer than 11 prescriptions). That is why these totals are higher than the count at the top of this page. Prescriptions include refills.
What it looks like
Pills from 5 makers on file. The same medicine can look different depending on who made it, so check the imprint (the letters and numbers on the pill) with your pharmacist if a refill looks different.
Aphena Pharma Solutions - Tennessee, LLC
| Strength | Looks like | Imprint |
|---|---|---|
| 30 mg | gray capsule, 16 mm | T001 |
Bryant Ranch Prepack
| Strength | Looks like | Imprint |
|---|---|---|
| 60 mg | blue capsule, 19 mm | T002 |
Golden State Medical Supply, Inc.
| Strength | Looks like | Imprint |
|---|---|---|
| 30 mg | gray capsule, 16 mm | T001 |
| 60 mg | blue capsule, 19 mm | T002 |
Remedyrepack Inc.
| Strength | Looks like | Imprint |
|---|---|---|
| 60 mg | blue capsule, 19 mm | T002 |
Upsher-Smith Laboratories, LLC
| Strength | Looks like | Imprint |
|---|---|---|
| 30 mg | gray capsule, 16 mm | T001 |
| 60 mg | blue capsule, 19 mm | T002 |
Source: DailyMed (U.S. National Library of Medicine), from each maker’s FDA drug listing. A few makers are shown, not every one. Never take a pill you can’t identify; ask a pharmacist.
Industry payments about this drug
No industry payments to clinicians named this drug in 2025.
Recalls and shortages
Not on the FDA drug shortage list.
No FDA-reported recalls since 2020.
Industry-funded trials
- A Study to Check the Safety of Dexlansoprazole and Learn if it Can Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Children 2 to 11 Years Old Completed · Takeda Pharmaceuticals U.S.A., Inc.
- A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old Terminated · Takeda Pharmaceuticals U.S.A., Inc.
Sources: CMS Medicare Part D Prescribers by Provider and Drug (2024; prescriptions include refills, and CMS hides counts under 11 per prescriber); U.S. Food and Drug Administration, openFDA (drug labels, NDC directory, enforcement reports, drug shortages); CMS Open Payments 2025; ClinicalTrials.gov. General information only, not medical advice; not yet reviewed by our medical reviewer.